| Literature DB >> 32623052 |
Tomás Pérez-Fernández1, Francisco Llinares-Pinel2, Mayte Troya-Franco2, Luis Fernández-Rosa3.
Abstract
OBJECTIVES: To analyze the microbiota of the physiotherapist's work environment to understand the existing potential risks and to adopt appropriate preventive measures.Entities:
Keywords: Cross infection; Infection control; Rehabilitation
Mesh:
Year: 2020 PMID: 32623052 PMCID: PMC7331516 DOI: 10.1016/j.apmr.2020.06.006
Source DB: PubMed Journal: Arch Phys Med Rehabil ISSN: 0003-9993 Impact factor: 3.966
Criterion for collection and numbering of the samples
| Sample Groups | Samples |
|---|---|
| Treatment table, A | |
| 1 | Head section |
| 2 | Intermediate section |
| 3 | Caudal section |
| Instruments and equipment, B | |
| 1 | Reusable sponge electrodes |
| 2 | Adhesive reusable electrode |
| 3 | Single use adhesive electrode |
| 4 | Ultrasound probe |
| 5 | Ultrasound gel |
| 6 | Short-wave electrodes |
| 7 | Laser probe |
| 8 | Cold packs |
| Physiotherapist, C | Hands |
| Ambient air, D | 250 liters of ambient air |
Absolute frequency of microorganism isolated from the samples studied
| Sample Type | Species | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Group A | Valid Samples | S.ep | C.fr | P.ag | A.b | St.m | S.au | S.s | Mc | M.ca | Aer | C.l | P.ae | P.nae | D.n | P.neu | K.r | P.m | S.ho |
| Head section of treatment table | 19 | 4 | 1 | − | − | − | − | − | − | − | 1 | − | − | 1 | 2 | 1 | 1 | − | 1 |
| Intermediate section of treatment table | 19 | 2 | − | 1 | 1 | − | − | 1 | − | − | − | − | − | − | − | − | − | 1 | − |
| Caudal section of treatment table | 19 | 3 | − | − | 1 | 1 | 1 | − | 1 | 1 | 1 | 1 | 1 | 1 | − | − | 1 | − | − |
| Total | 57 | 9 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 2 | 1 | 1 |
Abbreviations. A.l, Acinetobacter lwoffii; A.b, Acinetobacter baumannii; Aer, Aeromonas spp.; Bac, Bacillus spp.; C.l, Cedecea lapagei; C.br, Citrobacter braakii; C.fr, Citrobacter freundii; Cor, Corynebacterium spp; D.n, Dermacoccus nishinomiyaensis; E.col, Escherichia coli; Flv, Flavobacterium spp.; K.r, Kocuria rosea; Mc, Micrococcus spp.; M.ca, Moraxella catarrhalis; P.ae, Pseudomonas aeruginosa; P.ag, Pantoea agglomerans; P.m, Pasteurella multocida; P.nae, Pseudomonas no aeruginosa spp.; P.neu, Pasteurella pneumotropica; Pr.s, Providencia stuartii; S.au, Staphylococcus aureus; S.ep, Staphylococcus epidermidis; Ser.m, Serratia marcescens; Ser.r, Serratia rubidaea; S.ho, Staphylococcus hominis; S.hy, Staphylococcus hyicus; S.int, Staphylococcus intermedius; S.s, Staphylococcus sciuri; St.m, Stenotrophomonas maltophilia.
Relative frequency of microorganism isolated from the samples studied, expressed as percentages
| Sample Type | Species | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Group A | Valid Samples | S.ep | C.fr | P.ag | A.b | St.m | S.au | S.s | Mc | M.ca | Aer | C.l | P.ae | P.nae | D.n | P.neu | K.r | P.m | S.ho |
| Head section of treatment table | 19 | 21.0 | 5.3 | − | − | − | − | − | − | − | 5.3 | − | − | 5.3 | 10.5 | 5.3 | 5.3 | − | 5.3 |
| Intermediate section of treatment table | 19 | 10.5 | − | 5.3 | 5.3 | − | − | 5.3 | − | − | − | − | − | − | − | − | − | 5.3 | − |
| Caudal section of treatment table | 19 | 15.8 | − | − | 5.3 | 5.3 | 5.3 | − | 5.3 | 5.3 | 5.3 | 5.3 | 5.3 | 5.3 | − | − | 5.3 | − | − |
| Total | 57 | 15.8 | 1.7 | 1.7 | 3.5 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 3.5 | 1.7 | 1.7 | 3.5 | 3.5 | 1.7 | 3.5 | 1.7 | 1.7 |
Abbreviations. A.l, Acinetobacter lwoffii; A.b, Acinetobacter baumannii; Aer, Aeromonas spp.; Bac, Bacillus spp.; C.l, Cedecea lapagei; C.br, Citrobacter braakii; C.fr, Citrobacter freundii; Cor, Corynebacterium spp; D.n, Dermacoccus nishinomiyaensis; E.col, Escherichia coli; Flv, Flavobacterium spp.; K.r, Kocuria rosea; Mc, Micrococcus spp.; M.ca, Moraxella catarrhalis; P.ae, Pseudomonas aeruginosa; P.ag, Pantoea agglomerans; P.m, Pasteurella multocida; P.nae, Pseudomonas no aeruginosa spp.; P.neu, Pasteurella pneumotropica; Pr.s, Providencia stuartii; S.au, Staphylococcus aureus; S.ep, Staphylococcus epidermidis; Ser.m, Serratia marcescens; Ser.r, Serratia rubidaea; S.ho, Staphylococcus hominis; S.hy, Staphylococcus hyicus; S.int, Staphylococcus intermedius; S.s, Staphylococcus sciuri; St.m, Stenotrophomonas maltophilia.
Results of the analysis of the variance and the Student t test on the Group B samples (instruments)
| ANOVA | |
|---|---|
| Differences between groups | |
| Intra-group differences | NS |
NOTE. B3 and B6 samples are not included because no microbiological contamination was found in these fomites.
Abbreviations: ANOVA, analysis of variance; LSD, least significant difference; NS, not significant.
Fig 1Total number of different species isolated in each type of sample.